Guideline for the management of pediatric off-label use of drugs in China (2021)

• Main Authors: Min Meng (Author), Enmei Liu (Author), Bo Zhang (Author), Quan Lu (Author), Xiaobo Zhang (Author), Bin Ge (Author), Ye Wu (Author), Li Wang (Author), Mo Wang (Author), Zhengxiu Luo (Author), Ziyu Hua (Author), Xiaoling Wang (Author), Wei Zhao (Author), Yi Zheng (Author), Xinan Wu (Author), Ruiling Zhao (Author), Wenbo Meng (Author), Li Xiang (Author), Gang Wang (Author), Yuntao Jia (Author), Yongchuan Chen (Author), Xiaoyan Dong (Author), Lina Hao (Author), Chengjun Liu (Author), Meng Lv (Author), Xufei Luo (Author), Yunlan Liu (Author), Quan Shen (Author), Wenjuan Lei (Author), Ping Wang (Author), Yajia Sun (Author), Juanjuan Zhang (Author), Ling Wang (Author), Ruobing Lei (Author), Tianchun Hou (Author), Bo Yang (Author), Qiu Li (Author), Yaolong Chen (Author)
• Format: Book
• Published: BMC, 2022-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The "Law on Doctors of the People's Republic of China," which was officially implemented on March 1, 2022, emphasizes the requirements for rational drug use and the necessity for appropriate management of off-label drug use. The safety and ethical considerations re...